Asia Pacific Cold Pain Therapy Market

The Asia Pacific cold pain therapy market is expected to grow from US$ 315.63 million in 2022 to US$ 476.61 million by 2028. It is estimated to record a CAGR of 7.1% from 2022 to 2028.

High Adoption of Cold Pain Therapy in Emerging Economies to Drive Asia Pacific Cold Pain Therapy Market During 2022–2028

Cold pain therapy includes using cold material, such as cold packs, to reduce swelling, muscle spasms, and inflammation. The emerging economies have a large patient pool of geriatric and obese people that are prone to orthopedic conditions. According to the Technical Group on Population Projections for India report, there were ~138 million people in the country aged 60 years and above in 2021, which is expected to increase to ~156 million people by 2031. Moreover, an increase in healthcare expenditure leading to the development of healthcare services and infrastructure and a rise in medical tourism are expected to create significant opportunities for the cold pain therapy market in Asia Pacific in the coming years. According to the Indian Society for Trauma and Acute Care, road accidents are increasing at an annual rate of 3%. Furthermore, 22.8% of all traumas were related to transport-related injuries in India in 2020. Thus, the high adoption of cold pain therapy in emerging economies, such as India, owing to the rising geriatric and obese population and growing road accident and trauma cases are expected to create lucrative opportunities for the Asia Pacific cold pain therapy market players during the forecast period.

Market Overview

Asia Pacific is the fastest-growing regional market for cold pain therapy. The Asia Pacific cold pain therapy market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. Asia Pacific accounted for 13.48% of the global market share in 2021, owing to the high prevalence of musculoskeletal diseases, rising aging population, and increasing incidence of sports injuries. Therefore, the region would hold huge potential for the cold pain therapy market players to grow during the forecast period.

China’s population is rapidly aging at an earlier stage of its development than other countries. As per the survey by the US Census Bureau, the older population in China in 2030 would be 17.2% of the world’s total population. With an increase in the aging population, the number of orthopedic conditions has constantly increased over the previous years. Furthermore, increasing adoption of cold pain therapies along with traditional Chinese medicine and rising expansion of various global market players are likely to drive the growth of the cold pain therapy market in the country during the forecast period. Additionally, increase in R&D activities by market players to enhance efficiency of existing devices along with new product launches in the cold pain therapy market is expected to bolster the Asia Pacific cold pain therapy market growth during the forecast period.

Asia Pacific Cold Pain Therapy Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Cold Pain Therapy Strategic Insights

Strategic insights for the Asia Pacific Cold Pain Therapy provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Cold Pain Therapy Report Scope

Asia Pacific Cold Pain Therapy Regional Insights

The geographic scope of the Asia Pacific Cold Pain Therapy refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Asia Pacific Cold Pain Therapy Market Segmentation 

The Asia Pacific cold pain therapy market is segmented on the basis of application, offering, end user, and country. Based on application, the Asia Pacific cold pain therapy market is segmented into Runner's knee, tendonitis, sprains/sports sprain, arthritis pain, pain & swelling after a hip or knee replacement, pain & swelling under a cast or a splint, surgery recovery, lower back pain, and others. The surgery recovery segment held the largest market share in 2022.

Based on offering, the Asia Pacific cold pain therapy market is segmented into over-the-counter, prescription products, rehabilitation exercises, ice wraps & cold packs, pads, compression therapy, ice buckets without compression, and others. The over-the-counter segment held the largest market share in 2022.

Based on end user, the Asia Pacific cold pain therapy market is segmented into hospitals, clinics, rehabilitation centers, ambulatory surgical centers, individuals, and others. The hospitals segment held the largest share of the market in 2022.  

Based on country, the Asia Pacific cold pain therapy market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the market in 2022.

Cardinal Health Inc, DJO Global Inc, Ossur hf, and Sichuan Jiuyuan Medical Technology Co Ltd are among the leading companies operating in the Asia Pacific cold pain therapy market.